Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jane Elizabeth Brock, M.B.,B.Ch., Ph.D.

Concepts (173)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms282024210651.060 Why?
Receptors, Estrogen6202322020.780 Why?
Carcinoma, Intraductal, Noninfiltrating520199380.540 Why?
Fibroma120171900.520 Why?
Tamoxifen120209630.510 Why?
Receptor, erbB-25201825440.490 Why?
Sentinel Lymph Node Biopsy220187270.470 Why?
Carcinoma, Ductal, Breast3201810940.430 Why?
Cost Savings120189200.420 Why?
Mastectomy, Segmental520199650.420 Why?
Mastectomy5201818340.400 Why?
Neoplasm Recurrence, Local8202392740.400 Why?
Receptors, Progesterone3201811220.390 Why?
Immunohistochemistry62018110640.330 Why?
Carcinoma, Lobular320184900.300 Why?
In Situ Hybridization, Fluorescence2201125000.290 Why?
RNA, Messenger12021127620.270 Why?
Carcinoma2201823340.240 Why?
Nerve Sheath Neoplasms120051670.230 Why?
Patient Readmission2201933270.220 Why?
Guideline Adherence1201322830.210 Why?
Axilla220186180.210 Why?
Inflammatory Breast Neoplasms120241460.200 Why?
Rwanda220216620.190 Why?
Lymph Node Excision3201813050.180 Why?
Hospitals1201339290.170 Why?
Women's Health Services12020890.170 Why?
Diabetes Mellitus1201858840.170 Why?
Lymphatic Metastasis3201829450.160 Why?
Neoplasm Invasiveness5201536180.160 Why?
Nitriles120249550.160 Why?
Antibodies, Monoclonal3201191960.160 Why?
Developed Countries120204430.140 Why?
Standard of Care120205520.130 Why?
Paclitaxel1202417380.130 Why?
Nipples120182210.130 Why?
Female3120243910110.130 Why?
Practice Guidelines as Topic1201374680.130 Why?
Keratins120174970.130 Why?
Paget's Disease, Mammary12015190.130 Why?
Hemangiosarcoma120182180.130 Why?
Pathology, Surgical120161510.130 Why?
Hyperplasia1201811580.120 Why?
Aged, 80 and over112019589470.120 Why?
Pathology, Clinical120173750.110 Why?
Vascular Endothelial Growth Factor Receptor-2120165440.110 Why?
Anilides120164090.110 Why?
Pyrazoles1202419920.110 Why?
Self Care120187930.110 Why?
Humans3620247602610.100 Why?
Proto-Oncogene Proteins c-met120165670.100 Why?
Neoplasm Staging72018111410.100 Why?
Pyrimidines1202430110.100 Why?
Developing Countries2202128800.100 Why?
B-Lymphocytes1202447390.090 Why?
Prognosis52020296360.090 Why?
Receptor, Notch1120134950.090 Why?
False Negative Reactions120115740.090 Why?
Aged1620241689950.090 Why?
Risk Adjustment120136010.080 Why?
Immunoenzyme Techniques1201217050.080 Why?
Residence Characteristics1201920580.080 Why?
Middle Aged1920242201750.080 Why?
Medical Oncology1202023210.080 Why?
Medical Errors1201612550.080 Why?
Combined Modality Therapy3201985510.080 Why?
Clinical Laboratory Techniques120137490.080 Why?
Follow-Up Studies62019392540.070 Why?
Observer Variation1201325960.070 Why?
Adult1620242198470.070 Why?
Staining and Labeling1201110900.070 Why?
Gene Dosage1201112180.070 Why?
T-Lymphocytes12024101830.070 Why?
Quality Assurance, Health Care1201621780.070 Why?
Socioeconomic Factors1202078030.070 Why?
Diagnosis, Differential22018129680.060 Why?
Genetic Testing1201835300.060 Why?
Retrospective Studies102023803010.060 Why?
Radiotherapy Dosage1201128970.060 Why?
Rabbits1201147730.060 Why?
Pyridines1201628770.060 Why?
Mammography3202424520.060 Why?
Neoadjuvant Therapy3202428110.060 Why?
Antineoplastic Combined Chemotherapy Protocols32024117080.060 Why?
Sclerosis120242100.060 Why?
Microscopy, Electron, Transmission120056970.060 Why?
Neoplasm Metastasis2201648910.060 Why?
Angiogenesis Inhibitors1201320470.050 Why?
Analysis of Variance1201162420.050 Why?
Antibodies1201124240.050 Why?
Genome, Human1201644160.050 Why?
Survival Rate22018128060.050 Why?
Radiotherapy, Adjuvant2201917900.050 Why?
Sensitivity and Specificity12017146560.050 Why?
Clinical Trials as Topic1201880580.050 Why?
Reoperation1201142920.050 Why?
Societies, Medical1201339030.050 Why?
Breast Diseases120244430.050 Why?
Antineoplastic Agents32013136290.040 Why?
Kaplan-Meier Estimate3201665450.040 Why?
Neoplasm Proteins1201136130.040 Why?
Hospital Mortality1201354200.040 Why?
BRCA2 Protein120247970.040 Why?
Maryland120192750.040 Why?
Chromosome Aberrations1200517670.040 Why?
Mutation32024299500.040 Why?
Drug Delivery Systems1200922180.040 Why?
Poverty Areas120192640.040 Why?
Chemotherapy, Adjuvant2201835310.040 Why?
BRCA1 Protein1202411460.040 Why?
Treatment Outcome42024649470.030 Why?
Vascular Endothelial Growth Factor D12016640.030 Why?
Cost-Benefit Analysis1200955070.030 Why?
Soft Tissue Neoplasms1200511510.030 Why?
Young Adult32017586730.030 Why?
United States22013723630.030 Why?
Medicare1201367710.030 Why?
Reproducibility of Results12013200480.030 Why?
Time Factors22015401330.030 Why?
Breast1202419800.030 Why?
Africa South of the Sahara120177430.030 Why?
Interleukin-61202432070.030 Why?
Predictive Value of Tests22024152730.030 Why?
Retreatment120156000.030 Why?
MicroRNAs1200937840.030 Why?
Gene Expression Regulation, Neoplastic1200984980.030 Why?
Genes, BRCA2120166040.030 Why?
Medical Records1201814070.030 Why?
Magnetic Resonance Imaging22024362470.030 Why?
Genes, BRCA1120167690.030 Why?
Mutagenesis1201612340.020 Why?
Biopsy1202467750.020 Why?
Autoimmune Diseases1202422500.020 Why?
Medroxyprogesterone11990350.020 Why?
DNA, Neoplasm1201617450.020 Why?
Oncogenes1201612210.020 Why?
SEER Program1201515320.020 Why?
Integrin alpha512009200.020 Why?
Adolescent12017877470.020 Why?
DNA Replication1201614120.020 Why?
Biopsy, Needle1201416330.020 Why?
Frizzled Receptors12009900.020 Why?
Tumor Burden1201518970.020 Why?
Consensus1201831060.020 Why?
Neoplasm, Residual1201310080.020 Why?
rhoA GTP-Binding Protein120092350.020 Why?
DNA Mutational Analysis1201641090.020 Why?
Prospective Studies12011542630.020 Why?
Disease-Free Survival1201668300.020 Why?
Molecular Targeted Therapy1201628050.020 Why?
Animals320131679400.020 Why?
Risk Factors32019742690.020 Why?
Cell Line, Tumor22013169050.010 Why?
Cytoskeletal Proteins1200913440.010 Why?
Mammaplasty1201312390.010 Why?
Referral and Consultation1201635980.010 Why?
Cohort Studies22016413170.010 Why?
Gene Expression Profiling1201893880.010 Why?
Genetic Predisposition to Disease12024177660.010 Why?
Receptors, G-Protein-Coupled1200912440.010 Why?
Massachusetts1201488050.010 Why?
Genomics1201657900.010 Why?
Protein Kinase Inhibitors1201656400.010 Why?
Proportional Hazards Models12013125320.010 Why?
Male320193594130.010 Why?
Incidence12014213780.010 Why?
Membrane Proteins1200978540.010 Why?
Postoperative Complications12013156800.010 Why?
Medroxyprogesterone Acetate119901550.010 Why?
Biological Availability119903950.010 Why?
Mice12013812160.000 Why?
Administration, Oral1199040440.000 Why?
Pilot Projects1199085530.000 Why?
Brock's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (173)
Explore
_
Co-Authors (70)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.